MIM
TELA icon

Meros Investment Management’s TELA Bio TELA Stock Holding History

Meros Investment Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-152,718
Closed -$718K – 44
2024
Q2 		$718K Buy
152,718
+2,379
+2% +$12.5K 0.34% 38
2024
Q1 		$852K Buy
150,339
+70,400
+88% +$464K 0.38% 39
2023
Q4 		$529K Buy
+79,939
New +$462K 0.25% 41

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Meros Investment Management's TELA Position: Q3 2024 in Review

Meros Investment Management sold out of TELA Bio (TELA) in Q3 2024, closing a stake of 152,718 shares — an estimated $718K sold.

Meros Investment Management first reported a position in TELA in Q4 2023 and held it in 3 quarters. The position peaked at $852K in Q1 2024. 49 funds tracked by Wall St. Rank hold TELA as of Q3 2024.

  • Meros Investment Management reported no remaining TELA Bio position as of Q3 2024 after selling out during the quarter.
  • Meros Investment Management sold 152,718 TELA Bio shares in Q3 2024, an estimated $718K.
  • Meros Investment Management first reported a position in TELA Bio in Q4 2023 and held it in 3 quarters.
  • Meros Investment Management's TELA Bio position peaked at $852K in Q1 2024.
  • 49 funds tracked by Wall St. Rank held TELA Bio as of Q3 2024.

Based on Meros Investment Management's 13F filing for Q3 2024, filed 18 Nov 2024.